Cuba encouraged by early trials of homegrown COVID-19 vaccine


Reuters | Havana | Updated: 20-06-2021 05:53 IST | Created: 20-06-2021 05:53 IST
Cuba encouraged by early trials of homegrown COVID-19 vaccine
  • Country:
  • Cuba

Cuba's Soberana 2 vaccine candidate has shown 62% efficacy with just two of its three doses, state-run biopharmaceutical corporation BioCubaFarma said on Saturday, citing preliminary data from late phase trials.

Cuba, which has a decades-old reputed biotech sector, has five vaccine candidates in clinical trials, of which two - Soberana 2 and Abdala - are in late phase trials.

Also Read: Drop in Havana COVID-19 cases boosts hopes Cuban vaccines working

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

  • READ MORE ON:
  • Cuba
Give Feedback